Chiang DJ, Pritchard MT, Nagy LE. Obesity, diabetes mellitus, and liver brosis. Am J Physiol Gastrointest Liver Physiol. 2011;300(5):G697-702.
Article CAS PubMed PubMed Central Google Scholar
Fall T, ve Ingelsson E. Genome-wide association studies of obesity and metabolic syndrome. Mol Cell Endocrinol. 2014;382(1): 740–757.
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425–32.
Article CAS PubMed Google Scholar
Özen ŞV, Özen G. Leptin hormone: relationship with exercise and obesity. Sport Sciences. 2011;6(2):114–27.
Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity. inflammaion and insulin resistance. Eur Cytokine Netw. 2006;17(1):4–12.
Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998;395:763–70.
Article CAS PubMed Google Scholar
Lee GH, Proenca R, Montez JM, et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996;379:632–635.
Kaplan LM. Leptin, obesity, and liver disease. Gastroenterology. 1998;115:997–1001.
Article CAS PubMed Google Scholar
La Cava A, Matarese G. The weight of leptin in immunity. Nat Rev Immunol. 2004;4(5):371–9.
Calabro P, Limongelli G, Pacileo G, Salvo GD, Golino P, Calabro R. The role of adiposity as a determinant of an inflammatory milieu. J Cardiovasc Med. 2007;8:1–11.
Shangang Z, Yi Z, Robbi DS, Na L, Zhenyan H, Zhuzhen Z, Alexandre C, Qingzhang Z, Kai S, Wei X, Hui D, Jia S, Yingfeng D, Min K, et al. Partial leptin reduction as an insulin sensitization and weight loss strategy. Cell Metab. 2019;30(4):706-719.e6.
Ricci C, et al. The impact of CPT1B rs470117, LEPR rs1137101 and BDNF rs6265 polymorphisms on the risk of developing obesity in an Italian population. Obes Res Clin Pract. 2021;15(4):327–33.
Comba A, et al. Leptin ve metabolik etkileri. YYU Veteriner Fakultesi Dergisi. 2014;25(3):87–91.
Stepien M, Rosniak-Bak K, Paradowski M, Misztal M, Kujawski K, Banach M, et al. Waist circumference, ghrelin and selected adipose tissue-derived adipokines as predictors of insulin resistance in obese patients: preliminary results. Med Sci Monit. 2011;17:PR13-18.
Article CAS PubMed PubMed Central Google Scholar
Reinehr T, Kratzsch J, Kiess W, Andler W. Circulating soluble leptin receptor, leptin, and insülin resistance before and after weight loss in obese children. Int J Obese (Lond). 2005;29(10):1230–5.
Cui H, López M, Rahmouni K. The cellular and molecular bases of leptin and ghrelin resistance in obesity. Nat Rev Endocrinol. 2017;13(13):338–51.
Article CAS PubMed PubMed Central Google Scholar
Oswal A, Yeo G. Leptin and the control of body weight: a review of its diverse central targets, signaling mechanisms, and role in the pathogenesis of obesity. Obesity. 2010;18:221–9.
Terauchi Y, Matsui J, Kamon J, Yamauchi T, Kubota N, Komeda K, et al. Increased serum leptin protects from adiposity despite the increased glucose uptake in white adipose tissue in mice lacking p85alpha phosphoinositide 3-kinase. Diabetes. 2004;53:2261–70.
Article CAS PubMed Google Scholar
Jaworek J, Bonior J, Pierzchalski P, Tomaszewska R, Stachura J, Sendur R, et al. Leptin protects the pancreas from damage induced by caerulein overstimulation by modulating cytokine production. Pancreatology. 2002;2:89–99.
Article CAS PubMed Google Scholar
Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med. 2002;346(8):570–8.
Article CAS PubMed Google Scholar
Kim HJ, Lee SY, Kim CM. Association between gene polymorphisms and obesity and physical fitness in Korean children. Biol Sport. 2018;35(1):21–7.
Raskiliene A, Smalinskiene A, Kriaucioniene V, Lesauskaite V, Petkeviene J. Associations of MC4R, LEP, and LEOPR polymorphisms with obesity-related parameters in childhood and adulthood. Genes (Basel). 2021;12(6):949.
Article CAS PubMed Google Scholar
Jimenez-Osorio AS, Musalem-Younes C, Cardenas-Hernandez H, Solares-Tlapechco J, Urrutia PC, Medina-Contreras O, Granados J, et al. Common polymorphisms linked to obesity and cardiovascular disease in Europeans and Asians are associated with type 2 diabetes in Mexican Mestizos. Medicina (Kaunas). 2019;55(2):40.
Bennett CD, et al. The LightTyperTM: high-throughput genotyping using fluorescent melting curve analysis. Biotechniques. 2003;34(6):1288–95.
Article CAS PubMed Google Scholar
Farr OM, Gavrieli A, Mantzoros CS. Leptin applications in 2015: what have we learned about leptin and obesity? Curr Opin Endocrinol Diabetes Obes. 2015;22:353–9.
Article CAS PubMed PubMed Central Google Scholar
Izquierdo AG, Crujeiras AB. Leptin, Obesity, and Leptin Resistance: Where are We 25 Years Later? Nutrients. 2019;11: 2704.
Article CAS PubMed PubMed Central Google Scholar
Myers MG Jr, Heymsfield SB, Haft C, Kahn BB, Laughlin M, Leibel RL, et al. Challenges and opportunities of defining clinical leptin resistance. Cell Metab. 2012;15:150–6.
Article CAS PubMed PubMed Central Google Scholar
Ali EMM, et al. “Fat mass and obesity-associated (FTO) and leptin receptor (LEPR) gene polymorphisms in Egyptian obese subjects”. Archives of physiology and biochemistry 2021;127(1): 28–36.
Boumaiza I, et al. Relationship between leptin G2548A and leptin receptor Q223R gene polymorphisms and obesity and metabolic syndrome risk in Tunisian volunteers. Genetic testing and molecular biomarkers. 2012;16(7):726–33.
Article CAS PubMed PubMed Central Google Scholar
Bilge S, et al. The relationship of leptin (+ 19) AG, leptin (2548) GA, and leptin receptor Gln223Arg gene polymorphisms with obesity and metabolic syndrome in obese children and adolescents. Pediatric Gastroenterology, Hepatology and Nutrition. 2021;24(3):306.
Article PubMed PubMed Central Google Scholar
Diéguez-Campa CE, et al. Leptin levels and Q223R leptin receptor gene polymorphism in obese Mexican young adults. EJIFCC. 2020;31(3):197.
PubMed PubMed Central Google Scholar
Şahın S, et al. Investigation of associations between obesity and LEP G2548A and LEPR 668A/G polymorphisms in a Turkish population. Disease markers. 2013;35(6):673–7.
Comments (0)